anjana rao (Addgene inc)
Addgene inc is a verified supplier 
93
Structured Review
Addgene inc
anjana rao
Anjana Rao, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 69 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anjana+rao/MSCV-IRES-Thy1%2E1+DEST+(Plasmid+%2317442)/bio_rxiv__64898__2026__01__19__700325-157-13-15
Average 93 stars, based on 69 article reviews
Anjana Rao, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 69 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anjana+rao/MSCV-IRES-Thy1%2E1+DEST+(Plasmid+%2317442)/bio_rxiv__64898__2026__01__19__700325-157-13-15
Average 93 stars, based on 69 article reviews
anjana rao - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Clone Assay:Article Title: BCLAF1 links RNA splicing to ATF4-dependent metabolic adaptation in acute myeloid leukemia Article Snippet: pMSCV-IRES-GFP II (pMIG II) was a gift from Dario Vignali (Addgene plasmid #52107; RRID:Addgene_52107). pMIG-FLAG- MLL-AF9 was a gift from Daisuke Nakada (Addgene plasmid #71443; RRID:Addgene_71443). .. Cre was cloned into pMSCV-IRES-Thy1.1 to create pMIT-Cre. pMSCV-IRES-Thy1.1 was a gift from Plasmid Preparation:Article Title: BCLAF1 links RNA splicing to ATF4-dependent metabolic adaptation in acute myeloid leukemia Article Snippet: pMSCV-IRES-GFP II (pMIG II) was a gift from Dario Vignali (Addgene plasmid #52107; RRID:Addgene_52107). pMIG-FLAG- MLL-AF9 was a gift from Daisuke Nakada (Addgene plasmid #71443; RRID:Addgene_71443). .. Cre was cloned into pMSCV-IRES-Thy1.1 to create pMIT-Cre. pMSCV-IRES-Thy1.1 was a gift from Article Title: FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma Article Snippet: MSCV-IRES-Gfp was a gift from Tannishtha Reya (Addgene plasmid # 20672). .. MSCV-IRES-Thy1.1 DEST2 was a gift from Article Title: FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma Article Snippet: MSCV-IRES-Gfp was a gift from Tannishtha Reya (Addgene plasmid # 20672). .. MSCV-IRES-Thy1.1 DEST2 was a gift from Article Title: Dendritic cells type 1 control the formation, maintenance, and function of tertiary lymphoid structures in cancer Article Snippet: .. MSCV-IRES-Thy1.1 DEST was a gift from Article Title: Dendritic cells type 1 control the formation, maintenance, and function of tertiary lymphoid structures in cancer Article Snippet: .. MSCV-IRES-Thy1.1 DEST was a gift from Article Title: Inflammatory signaling pathways play a role in SYK inhibitor resistant AML Article Snippet: .. IKK-2 WT and IKK-2 S177E S181E were a gift from Article Title: IKBKB gain of function: An inborn error with clinical heterogeneity progressing toward combined immunodeficiency. Article Snippet: IKBKB gain of function: An inborn error with clinical heterogeneity progressing toward combined immunodeficiency Article Title: Inflammatory signaling pathways play a role in SYK inhibitor resistant AML. Article Snippet: .. IKK-2 WT and IKK-2 S177E S181E were a gift from Produced:Article Title: Dendritic cells type 1 control the formation, maintenance, and function of tertiary lymphoid structures in cancer Article Snippet: .. MSCV-IRES-Thy1.1 DEST was a gift from Article Title: Dendritic cells type 1 control the formation, maintenance, and function of tertiary lymphoid structures in cancer Article Snippet: .. MSCV-IRES-Thy1.1 DEST was a gift from Retroviral:Article Title: Dendritic cells type 1 control the formation, maintenance, and function of tertiary lymphoid structures in cancer Article Snippet: .. MSCV-IRES-Thy1.1 DEST was a gift from Article Title: Dendritic cells type 1 control the formation, maintenance, and function of tertiary lymphoid structures in cancer Article Snippet: .. MSCV-IRES-Thy1.1 DEST was a gift from Variant Assay:Article Title: IKBKB gain of function: An inborn error with clinical heterogeneity progressing toward combined immunodeficiency. Article Snippet: IKBKB gain of function: An inborn error with clinical heterogeneity progressing toward combined immunodeficiency Mutagenesis:Article Title: IKBKB gain of function: An inborn error with clinical heterogeneity progressing toward combined immunodeficiency. Article Snippet: IKBKB gain of function: An inborn error with clinical heterogeneity progressing toward combined immunodeficiency |